Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study

Abstract

ObjectivesThe rate of drug overdose deaths in the USA has more than tripled since the turn of the century, and rates are disproportionately high among the American Indian/Alaska Native (AI/AN) population. Little is known about the overall historical trends in AI/AN opioid-only and opioid/polysubstance-related mortality. This study will address this gap.DesignThis is a retrospective longitudinal ecological study.SettingUS death records from 1999 to 2019 using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research.ParticipantsUS non-Hispanic AI/AN people age 12 years and older.MeasuresThe primary outcomes, identified via the 10th revision of the International Statistical Classification of Diseases and Related Health Problems codes, included overdose deaths due to (1) opioids only, opioids in combination with any other substance, all-opioid related overdoses; (2) combinations of opioids and alcohol, opioids and methamphetamine, opioids and cocaine, opioids and benzodiazepines; and (3) specific types of opioids.ResultsFrom 1999 to 2019, opioid-only mortality rates increased from 2.8 to 15.8 per 100 000 (p<0.001) for AI/AN women and 4.6 to 25.6 per 100 000 (p<0.001) for AI/AN men. All opioid-related mortality rates increased significantly (p<0.001) from 5.2 to 33.9 per 100 000 AI/AN persons, 3.9 to 26.1 for women and 6.5 to 42.1 for men. AI/AN also exhibited significant increases in mortality rates due to opioids and alcohol, opioids and benzodiazepines, opioids and methamphetamine, and AI/AN men experienced substantial increases in mortality due to opioids and cocaine. Mortality rates by individual opioid types increased significantly over time for heroin, natural and semi-synthetic (prescription), and synthetic opioids (fentanyl/fentanyl analogues) other than methadone.ConclusionsThese findings highlight magnification over time in opioid-related deaths and may point to broader systemic factors that may disproportionately affect members of AI/AN communities and drive inequities.

Striatal hypoactivation during monetary loss anticipation in individuals with substance use disorders in a heterogenous urban American Indian sample

“…Much interdisciplinary research is needed to wed clinical neuroscience with culturally safe, community-driven treatment and prevention solutions. This study represents an important early step in a much broader process of engaging Indigenous communities with neuroscience to address persistent and widening gaps in SUD and related-health problems ( Qeadan et al, 2022 ; Wendt et al, 2021 ). In addition, replications of these findings in other populations would advance prior evidence of similar processing between AIs and general populations in SUD research ( Evans-Campbell et al, 2006 ; Robins et al, 1997; White et al, 2022 ).…”

Correlation Between Opioid Drug Prescription and Opioid-Related Mortality in Spain as a Surveillance Tool: Ecological Study

“…Subsequently, a description of the variables' evolution over time was carried out. We carried out an analysis of the correlation between the annual rates of ORM and the DHD of the prescribed opioid drugs globally, excluding medications of the least potential risk of overdose and lowest treatment tier [27] (codeine and tramadol), and separately, based on the frequency of their use or their growth over recent years from the initial descriptive analysis. The relationship between ORM and ODP was analyzed as follows: (1) total ODP, (2) total ODP excluding codeine, (3) total ODP excluding codeine and tramadol, (4) tramadol, (5) fentanyl, (6) tapentadol, (7) oxycodone (unifying presentations with and without naloxone), and (8) morphine.…”

Forever Changed: Predicting Grief and Growth After an Opioid-Related Loss

“…Most importantly, given our predominantly White female sample, future research should examine how these variables operate to predict outcomes for people of Color and men who are bereaved by an opioid-related death. Epidemiologic research suggested similar rates of opioid overdoses in White and Black communities and lower rates in Hispanic communities (Kaiser Family Foundation, 2022), a disproportionate impact of the opioid epidemic on Indigenous American communities (Qeadan et al, 2022), and rising levels of opioid-related mortality among Asian American and Pacific Islander individuals in recent years (Townsend et al, 2022).…”